A detailed history of Westchester Capital Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Westchester Capital Management, LLC holds 1,445,702 shares of CTLT stock, worth $85.3 Million. This represents 4.23% of its overall portfolio holdings.

Number of Shares
1,445,702
Previous 1,130,177 27.92%
Holding current value
$85.3 Million
Previous $63.5 Million 37.79%
% of portfolio
4.23%
Previous 2.61%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $17.7 Million - $19.2 Million
315,525 Added 27.92%
1,445,702 $87.6 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $7.95 Million - $8.46 Million
148,452 Added 15.12%
1,130,177 $63.5 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $41.8 Million - $58.7 Million
981,725 New
981,725 $55.4 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Westchester Capital Management, LLC Portfolio

Follow Westchester Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westchester Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westchester Capital Management, LLC with notifications on news.